EU approves Sanofi, Regeneron's Dupixent for adolescent eczema cases

The Dupixent product developed by French healthcare company Sanofi and its U.S. partner Regeneron has won regulatory approval in Europe for moderate-to-severe cases of eczema in adolescents, the companies said.

from Reuters: Health News https://ift.tt/2KhulbO
via IFTTT